FLAM
AMLX icon

First Light Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

First Light Asset Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.3M Sell
3,190,645
-164,894
-5% -$2.32M 3.97% 7
2025
Q4 		$40.5M Sell
3,355,539
-343
-0% -$4.66K 3.1% 10
2025
Q3 		$45.6M Buy
+3,355,882
New +$31.6M 4.3% 5

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

First Light Asset Management's AMLX Position: Q1 2026 in Review

First Light Asset Management reduced its Amylyx Pharmaceuticals (AMLX) stake by 4.9% in Q1 2026, selling an estimated $2.32M and leaving 3,190,645 shares worth $44.3M. The position accounts for 3.97% of the portfolio, ranked #7.

First Light Asset Management first reported a position in AMLX in Q3 2025 and has held it in 3 quarters since. The position peaked at $45.6M in Q3 2025. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • First Light Asset Management held 3,190,645 shares of Amylyx Pharmaceuticals worth $44.3M as of Q1 2026.
  • First Light Asset Management sold 164,894 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $2.32M.
  • Amylyx Pharmaceuticals made up 3.97% of First Light Asset Management's portfolio in Q1 2026, its #7 holding.
  • First Light Asset Management first reported a position in Amylyx Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • First Light Asset Management's Amylyx Pharmaceuticals position peaked at $45.6M in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on First Light Asset Management's 13F filing for Q1 2026, filed 15 May 2026.